Delivery Order SPE2DX22D0010-SPE2D826FAQ60
Award Date 10/27/25
Potential Completion Date 10/28/25
Potential Value $8.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Quillivant XR Oral Suspension 60ML 5MG/ML, a pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $4,940.45, represents a non-set-aside, competitively awarded contract with an ultimate completion date of August 21, 2025. The product will be supplied from...
- The Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Quillivant XR Oral Suspension 60ML 5MG/ML, a medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $2,736.97, is not set-aside and represents a competitive award under an existing indefinite delivery contract vehicle. The product will be delivered to the vendor's headquarters in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Quillivant XR Oral Suspension (60ML, 5MG/ML), a medication used to treat attention-deficit/hyperactivity disorder. This competitively awarded, non-set-aside contract carries a ceiling value of $5,195.61 with a firm fixed price structure and an ultimate completion date of December 8, 2025. The award was issued on December 5, 2025, and performance will occur at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Quillivant XR Oral Suspension 60ML 5MG/ML, a pharmaceutical product used in the treatment of attention deficit disorders. The award, valued at $9,205.46, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 120 ml quantity. This is a firm fixed-price delivery order with a ceiling value of $3,253.59 and an ultimate completion date of September 19, 2025. The award represents a non-competitive delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (180 mL), a pharmaceutical product used to treat attention deficit hyperactivity disorder. The contract is a firm fixed-price delivery order with a ceiling value of $3,893.03 and an ultimate completion date of November 26, 2025. This award was made on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,827.25 on October 23, 2025, with an ultimate completion date of October 24, 2025. The order is for Quillivant XR 25 mg/5 ml suspension in a 120 ml quantity, a brand-name ADHD medication. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for $3,357.82 on September 5, 2025, with an ultimate completion date of September 8, 2025. The contract covers the supply of Quillivant XR 25 mg/5 ml suspension (120 ml), an extended-release liquid formulation of methylphenidate used to treat attention deficit hyperactivity disorder. This is a firm fixed-price delivery order with no set-aside designation, issued as a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (120 mL), a medication used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, valued at $2,962.82, represents a non-competitive set-aside award and is scheduled for completion by September 23, 2025. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 1, 2025, for Quillivant XR 25 mg/5 mL suspension (120 mL) with a ceiling value of $1,615.19. This firm fixed-price delivery order is set to be completed by December 2, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The...